Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Iron-Fortified Whole Maize Flour Trial
This study is ongoing, but not recruiting participants.
Sponsors and Collaborators: Wageningen University
Unilever Food and Health Research Institute, The Netherlands
Kenya Medical Research Institute
Akzo Nobel
Information provided by: Wageningen University
ClinicalTrials.gov Identifier: NCT00386074
  Purpose

The purpose of this study is to assess whether NaFeEDTA and electrolytic iron improve iron status of young school children, when added as iron fortificants in whole maize flour.


Condition Intervention Phase
Anaemia
Drug: NaFeEDTA, Electrolytic Iron
Phase II

MedlinePlus related topics: Anemia
Drug Information available for: Phytic acid Sodium feredetate Phytate sodium
U.S. FDA Resources
Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Efficacy Study
Official Title: The Efficacy of Iron Fortified Whole Maize Flour on the Iron Status of School Children in Kenya

Further study details as provided by Wageningen University:

Primary Outcome Measures:
  • Haemoglobin
  • Plasma Ferritin
  • Plasma Transferrin receptor

Secondary Outcome Measures:
  • Iron deficiency anaemia
  • Iron deficiency
  • Anaemia

Estimated Enrollment: 412
Study Start Date: May 2004
Estimated Study Completion Date: December 2004
Detailed Description:

Fortification of staple foods with iron may be an effective method of addressing the problem of iron deficiency. Questions however remain of the type of iron fortificants to use, the appropriate fortification levels and suitable food vehicles. Cereals form attractive vehicles because they are widely consumed in parts of the world that bear a large burden of the iron deficiency problem. They are however high in phytates and would reduce the bioavailability of commonly used iron fortificants. Isotope studies have shown that even in the presence of phytates, iron from NaFeEDTA is relatively more bioavailable than that from other fortificant sources. Its efficacy has however not been assessed in human trials. Electrolytic iron, on the other hand is widely used and was legislated as the iron fortificant of choice in South Africa. Its efficacy in a high-phytate vehicle has also not been assessed. We have therefore undertaken to assess the efficacy of NaFeEDTA at two doses, as an iron fortificant in whole flour, and the efficacy of electrolytic iron at a dose similar to the high-dose NaFeEDTA. The results will contribute information on the suitability of these fortificants in whole maize flour, a food commonly consumed in sub-Saharan Africa.

  Eligibility

Ages Eligible for Study:   3 Years to 8 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:Children:

  • 3-8 years age (for the purposes of this study this will include children born within the period December 15th 1995- May 1st 2001).
  • Whohave been resident in the area for 6 months or more.
  • Enrolled in the selected schools
  • Able to consume the target amount of porridge, at least 50% of the time during the run-in period
  • Will be present in the study area for the entire study period (April – December 2004).

Exclusion Criteria:

  • Children below 3 years and above 8 years of age (born after December 15th 1995 and before May 1st 2001).
  • Children who have been resident in the area for less than 6 months at the time of recruitment.
  • Children with obvious physical and mental disability.
  • Severely malnourished children.
  • Severely anaemic children (Hb <70g/L).
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00386074

Sponsors and Collaborators
Wageningen University
Unilever Food and Health Research Institute, The Netherlands
Kenya Medical Research Institute
Akzo Nobel
Investigators
Principal Investigator: Pauline EA Andang'o, MND Wageningen University
Principal Investigator: David L Mwaniki, PhD Kenya Medical Research Institute
Principal Investigator: Hans Verhoef, PhD Wageningen University
Study Director: Saskia JM Osendarp, PhD Unilever Food and Health Institute, Vlaardingen, The Netherlands
Study Chair: Frans J Kok, PhD Wageningen University
  More Information

Publications indexed to this study:
Study ID Numbers: 6107050200
Study First Received: October 10, 2006
Last Updated: October 10, 2006
ClinicalTrials.gov Identifier: NCT00386074  
Health Authority: Kenya: Ethical Review Committee

Keywords provided by Wageningen University:
NaFeEDTA
electrolytic iron
efficacy
whole maize flour
phytate
school-age children
controlled trial
Africa

Study placed in the following topic categories:
Fe(III)-EDTA
Anemia
Iron

Additional relevant MeSH terms:
Molecular Mechanisms of Pharmacological Action
Growth Substances
Physiological Effects of Drugs
Iron Chelating Agents
Trace Elements
Chelating Agents
Micronutrients
Pharmacologic Actions

ClinicalTrials.gov processed this record on January 16, 2009